Gene · 2999
Papers1,418
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,418
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of drug candidates targeting monocyte reprogramming in people living with HIV. | Front Immunol | 2023 | 38077315 | PubTator, text mining | PubMed |
| Causes of microcephaly in human-theoretical considerations. | Front Neurosci | 2023 | 38075281 | PubTator, text mining | PubMed |
| Delineating the early dissemination mechanisms of acral melanoma by integrating single-cell and spatial transcriptomic analyses. | Nat Commun | 2023 | 38065972 | PubTator, text mining | PubMed |
Development and validation of a disulfidptosis-related scoring system to predict clinical outcome and immunotherapy response in acute myeloid leukemia by integrated analysis of single-cell and bulk RNA-sequencing. | Front Pharmacol | 2023 | 38053840 | PubTator, text mining | PubMed |
| Expression and clinical significance of PD-L1 and infiltrated immune cells in the gastric adenocarcinoma microenvironment. | Medicine (Baltimore) | 2023 | 38050283 | PubTator, text mining | PubMed |
| Young infants display heterogeneous serological responses and extensive but reversible transcriptional changes following initial immunizations. | Nat Commun | 2023 | 38042900 | PubTator, text mining | PubMed |
| Aging gene signature of memory CD8+ T cells is associated with neurocognitive functioning in Alzheimer's disease. | Immun Ageing | 2023 | 38042785 | PubTator, text mining | PubMed |
| Current Situation and Prospect of Adoptive Cellular Immunotherapy for Malignancies. | Technol Cancer Res Treat | 2023 | 38037341 | PubTator, text mining | PubMed |
| Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain. | Front Endocrinol (Lausanne) | 2023 | 38034001 | PubTator, text mining | PubMed |
| Natural killer cells in the central nervous system. | Cell Commun Signal | 2023 | 38031097 | PubTator, text mining | PubMed |
| PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma. | Nat Commun | 2023 | 38030622 | PubTator, text mining | PubMed |
| Unveiling the molecular Culprit of arterial stiffness in vitamin D deficiency and obesity: Potential for novel therapeutic targets. | Heliyon | 2023 | 38027669 | PubTator, text mining | PubMed |
| SLC22A3 that encodes organic cation transporter-3 is associated with prognosis and immunogenicity of human lung squamous cell carcinoma. | Transl Lung Cancer Res | 2023 | 38025816 | PubTator, text mining | PubMed |
| B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients. | Front Immunol | 2023 | 38022530 | PubTator, text mining | PubMed |
| TimiGP: An R package to depict the tumor microenvironment from bulk transcriptomics. | STAR Protoc | 2023 | 38019649 | PubTator, text mining | PubMed |
| An engineered glioblastoma model yields novel macrophage-secreted drivers of invasion. | bioRxiv | 2023 | 38014161 | PubTator, text mining | PubMed |
| Identification of biomarkers associated with pediatric asthma using machine learning algorithms: A review. | Medicine (Baltimore) | 2023 | 38013370 | PubTator, text mining | PubMed |
| CAR+ and CAR- T cells share a differentiation trajectory into an NK-like subset after CD19 CAR T cell infusion in patients with B cell malignancies. | Nat Commun | 2023 | 38012187 | PubTator, text mining | PubMed |
| GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers. | Genome Med | 2023 | 38008725 | PubTator, text mining | PubMed |
| Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies. | J Immunother Cancer | 2023 | 38007238 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2999/papers?page=8